SOHM Inc | Adds Life to LivesAdds life to lives

SOHM India Pvt. Ltd, an Indian subsidiary of SOHM, Inc. enters into an Agreement with Ranbaxy for Dermatology Products

posted in Press Releases article tags:

SOHM Gets Mandate from Ranbaxy in Dermatology Products

BUENA PARK, CA–(Marketwire – May 10, 2012) – SOHM, Inc. (PINKSHEETS: SHMN) is a globally known generic pharmaceutical manufacturer, developer and marketers having a vast range of products, covering almost all the therapeutic segments, is growing strength by strength with its thriving acquisitions and strategic tie-ups.

SOHM India Pvt. Ltd, an Indian subsidiary of SOHM, Inc. has entered into an principal-to-principal manufacturing agreement with one of the top leading Pharmaceutical companies- Ranbaxy Laboratories Limited, now part of Daiichi Sankyo Company Ltd., Japan which is the third largest drug-maker of JAPAN for marketing of “Speelac Face Wash Gel” that treats Acne and helps in reducing the Acne flare up quicker.

This has been made possible by strategic acquisition of Novatrend Medicament Pvt. Ltd. and its core competencies in dermatology. SOHM has been able to retain its IPR. SOHM ensures that its innovative focus is reinforced by adding a Foam preparation in its Salic-2 Face Wash product mix in the management of acne vulgarize.

Mr. Shailesh Shah, The president & C.E.O SOHM, Inc. has denoted, “these are only baby steps from building generics to branded generics to major R & D focus in time to come. The company motto of developing alternatives for unmet needs is increasingly getting reinforced with wider net work product innovation in the pipe line.”

About SOHM, Inc.

SOHM, Inc., a growing generic pharmaceutical manufacturing and marketing company, has its global presence with a goal to gain continuous growth. The company has its presence in versatile healthcare segments such as Nutraceuticals, Dermatology and all other major therapeutic segments. SOHM is headquartered in North America along with its manufacturing units in India. SOHM’s generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia mainly. To know more about SOHM, Inc., please visit

Forward-Looking Statements

This press release is containing many safe harbour statements such as, “project”, “plan”, “can”, etc., keeping in mind the guidelines of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For more information, please contact:
SOHM, Inc.
Andrew Barwicki